Skip to main content

and
  1. Article

    Open Access

    The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma

    Lenvatinib is appropriate for reducing the production of nitric oxide (NO) and facilitating as block angiogenesis. However, to our knowledge, there are no data that support the correlation between NO and clini...

    Atsushi Kawamura, Haruki Uojima, Makoto Chuma, Xue Shao, Hisashi Hidaka in BMC Cancer (2022)